Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhang, Lan ^a   Ma, Dejun ^a,b   Zhang, Yanning ^a   He, Weizhi ^a   Yang, Jingjing ^a,c   Li, Chuanren ^b   Jiang, Hongyun ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b YANGTZE UNIVERSITY   (China)

^c SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; HYDROXYCAMPTOTHECIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DNA TOPOISOMERASE 1 GENE; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION REGULATION; GENE FUNCTION; INSECTICIDAL ACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN PURIFICATION; SPODOPTERA EXIGUA; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; ELECTROPHORESIS, POLYACRYLAMIDE GEL; INSECTICIDES; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; SPODOPTERA;

EID: 84874339036     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056458     Document Type: Article

References (48)

1. Wang JC, (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3: 430-440.
2. Pommier Y, (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 6: 127-138.
3. Wall ME, Wani MC, Cook CE, Keith H, Palmer AT, et al. (1966) Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminate. J Am Chem Soc 88: 3888-3890.
4. Hsiang YH, Hertzberg R, Hecht S, Liu LF, (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 260: 14873-14878.
5. Hsiang YH, Liu LF, (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48: 1722-1726.
6. Lorence A, Nessler CL, (2004) Camptothecin, over four decades of surprising findings. Phytochemistry 65: 2735-2749.
7. Pommier Y, (2009) DNA topoisomerase I inhibotors: chemistry, biology, and interfacial inhibition. Chem Rev 109: 2894-2902.
8. DeMilo AB, Borkovec AB, (1974) Camptothecin, a potent chemosterilant against the housefly. J Econ Entomol 67: 457-458.
9. Lee PP, Brown SD, Chen A, Hsieh TS, (1993) DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci USA 90: 6656-6660.
10. Zhang XW, Xu B, (2000) Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells. Anticancer Drugs 11: 747-756.
11. Sortibrán AN, Téllez MG, Rodríguez-Arnaiz R, (2006) Genotoxic profile of inhibitors of topoisomerases I (camptothecin) and II (etoposide) in a mitotic recombination and sex-chromosome loss somatic eye assay of Drosophila melanogaster. Mutat Res 604: 83-90.
12. Tong S, Wang P, Zhang L, Ma J, Sheng X, (2009) Insecticidal effect of camptothecin against Nilaparvata lugens, Brevicoryn brassicae and Chilo suppressalis Walker. Acta Agriculturae Zhejiangensis 21: 288-282.
13. Zou S, Zhang Y, Cheng M, Li D, Zhang B, (2010) Influence of camptothecin to Bactrocera dorsali. Guangdong Agricultural Sciences 2: 89-92.
14. Liu YQ, Dai W, Tian J, Yang L, Feng G, et al. (2011) Synthesis and insecticidal activities of novel spin-labeled derivatives of camptothecin. Heteroatom Chem 22: 687-691.
15. Liu YQ, Yang L, Zhao YL, Li HY, (2010) Synthesis of novel derivatives of camptothecin as potential insecticides. Pestic Biochem Physiol 98: 219-223.
16. Zhang L, Zhang YN, He WZ, Ma DJ, Jiang HY, (2012) Effects of camptothecin and hydroxycamptothecin on insect cell lines Sf21 and IOZCAS-Spex-II. Pest Manag Sci 68: 652-657.
17. Lee PP, Brown SD, Chen A, Hsieh TS, (1993) DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci USA 90: 6656-6660.
18. Hsieh TS, Brown SD, Huang P, Fostel J, (1992) Isolation and characterization of a gene encoding DNA topoisomerase I in Drosophila melanogaster. Nucleic Acids Res 20: 6177-6182.
19. Zhang CX, Chen AD, Gettel NJ, Hsieh TS, (2000) Essential functions of DNA topoisomerase I in Drosophila melanogaster. Dev Biol 222: 27-40.
20. Redinbo MR, Stewart L, Kuhn P, Champoux JJ, Hol QGJ, (1998) Crystal structures of Human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279: 1504-1513.
21. Cheng C, Kussie P, Pavletich N, Shuman S, (1998) Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell 92: 841-850.
22. Sirikantaramas S, Yamazaki M, Saito K, (2008) Mutations in topoisomerase I as a self-resistance mechanism coevolved with the production of the anticancer alkaloid camptothecin in plants. Proc Natl Acad Sci USA 105: 6782-6786.
23. Kusari S, Košuth J, Čellárová E, Spiteller M, (2011) Survival-strategies of endophytic Fusarium solani against indigenous camptothecin biosynthesis. Fungal Ecol 4: 219-223.
24. Fujimori A, Harker WG, Kohlhagen G, Hoki Y, Pommier Y, (1995) Mutation at the catalytic site of topoisomerase I in GEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res 55: 1339-1346.
25. Chrencik JE, Staker BL, Burgin AB, Pourquier P, Pommier Y, et al. (2004) Mechanisms of camptothecin resistance by human topoisomerase I mutations. J Mol Bio 339: 773-784.
26. Gongora C, Vezzio-Vie N, Tuduri S, Denis V, Causse A, et al. (2011) New Topoisomerase I mutations are associated with resistance to camptothecin. Mol Cancer 10: 64-76.
27. Chang JY, Liu JF, Juang SF, Liu TW, Chen LT, (2002) Novel mutation of topoisomerase I in rendering cells resistant to camptothecin. Cancer Res 62: 3716-3721.
28. Chillemi G, D'Annessa, Fiorani P, Losasso C, Benedetti P, et al. (2008) Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations. Nucleic Acids Res 36: 5645-5651.
29. Losasso C, Cretaio E, Fiorani P, D'Annessal I, Chillemi G, et al. (2008) A single mutation in the 729 residue modulateds human DNA topoisomerase IB DNA binding and drug resistance. Nucleic Acids Res 36: 5635-5644.
30. Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, et al. (2008) Dynamic proteomics of individual cancer cells in response to a drug. Science 322: 1511-1516.
31. Yun HJ, Kim SY, Kwon YY, Kim CH, Kang CM, et al. (2010) Janus-activated kinases and signal transducer and activator of transcription control tumor growth response to camptothecin in human colon cancer cells. Cancer Biol Ther 10: 354-361.
32. Sugimoto Y, Tsukahara S, Oh-hara T, Isoe T, Tsuruo T, (1990) Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res 50: 6925-6930.
33. Husain I, Mohler JL, Seigler HF, Besterman JM, (1994) Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 15: 539-546.
34. Sirikantaramas S, Sudo H, Asano T, Yamazaki M, Saito K, (2007) Transport of camptothecin in hairy roots of Ophiorrhiza pumila. Phytochemistry 68: 2881-2886.
35. Sirikantaramas S, Yamazaki M, Saito K, (2009) A survival strategy: the coevolution of camptothecin biosynthetic pathway and self-resistance mechanism. Phytochemistry 70: 1894-1898.
36. Yang L, Cui F, Cun D, Tao A, Shi K, et al. (2007) Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Int J Pharm 340: 163-172.
37. Staker BL, Hjerrild K, Feese MD, Behnke CA, Cushman M, et al. (2002) The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci USA 99: 15387-15392.
38. Zhou JJ, Liu J, Xu B, (2001) Relationship between lactone ring forms of HCPT and their antitumor activities. Acta Pharmacol Sin. 22: 827-830.
39. Buckwalter CA, Lin AH, Tanizawa A, Pommier YG, Cheng YC, et al. (1996) RNA synthesis inhibitors alter the subclear distribution of DNA topoisomerase I. Cancer Res. 56: 1674-1681.
40. Capranico G, Marinello J, Baranello L, (2010) Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: implications for physiological and therapeutic modulation of enzyme activity. Biochimica et Biophysica Acta 1806: 240-250.
41. Saito N, Nei M, (1987) The neighbor-joining method: a new method for resconstructing phylogenic trees. Mol Biol Evol 4: 406-425.
42. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
43. Bradford MM, (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7: 248-254.
44. Stewart L, Champoux JJ, (2001) Assaying DNA topoisomerase I relaxation activity. Methods Mol Biol 95: 1-11.
45. Stewart L, Champoux JJ, (1999) Purification of baculovirus-expressed human DNA topoisomerase I. Methods Mol Biol. 94: 223-234.
46. Sakuma M, (1998) Probit analysis of preference data. J Appl Entomol Zool 33: 339-347.
47. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: 2002-2007.
48. Fu Q, Kim SW, Chen HX, Grill S, Cheng YC, (1999) Degradation of topoisomerase I induced by topoisomerase I inhibitiors is dependent on inhibitor structure but independent of cell death. Mol Pharmacol 55: 667-683.